News & Analysis as of

Public Health Manufacturers European Union

Morris James LLP

Analyzing the Impact of Recent Studies Linking Depo-Provera to Increased Meningioma Risk

Morris James LLP on

Recent scientific research has uncovered a significant association between the long-term use of Depo-Provera, a widely used injectable contraceptive, and the development of meningiomas, tumors affecting the membranes...more

Hogan Lovells

EU bans BPA in Food Contact Materials: what does it mean for industry?

Hogan Lovells on

Jacqueline Mailly and Anastasia Vernikou of Hogan Lovells and Grégoire Paquet outline the details of the EU regulation introducing a ban on Bisphenol A (BPA) in food contact materials and its implications for industry. On 20...more

Gardner Law

Transatlantic Legal-Regulatory Update: Live from the Heart of Silicon Valley

Gardner Law on

US and EU Life Sciences Law firms Fieldfisher & Gardner Law recently held a CLE event in Silicon Valley covering Healthcare Compliance, Data Privacy and Regulatory hot topics for MedTech and Pharma companies. Discussion...more

Hogan Lovells

Brexit and REACH: What does it mean for products companies?

Hogan Lovells on

With the EU Chemical Agency's recent announcement that four new substances will be added to the Candidate List1, you might be thinking: what's next for the UK and its chemicals legislation?...more

Jones Day

Intentional or Not? Questions Loom Over EU's Proposed Micro-Plastic Particle Restrictions

Jones Day on

The Situation: The European Commission ("Commission") has requested that the European Chemicals Agency ("ECHA") investigate the need for an EU-wide restriction on "intentionally added' micro-plastic particles. The...more

Jones Day

ECHA Proposes to Include 18 New Substances in REACH

Jones Day on

On September 5, 2018, the European Chemicals Agency ("ECHA") launched a public consultation to include 18 new substances in Annex XIV REACH. REACH, the acronym for the Registration, Evaluation, Authorisation and Restriction...more

6 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide